* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Steven A. Porcelli, M.D.
Survey
Document related concepts
Molecular mimicry wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Innate immune system wikipedia , lookup
Immune system wikipedia , lookup
Duffy antigen system wikipedia , lookup
Social immunity wikipedia , lookup
Herd immunity wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Adaptive immune system wikipedia , lookup
DNA vaccination wikipedia , lookup
Vaccination wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Immunocontraception wikipedia , lookup
Transcript
Steven A. Porcelli, M.D. Professor and Chair, Microbiology & Immunology Professor, Medicine (Rheumatology) The Murray and Evelyne Weinstock Chair in Microbiology and Immunology Dr. Porcelli received his M.D. degree in 1984 from Yale University, and completed a medical residency at Temple University Hospital in 1987. He was a fellow and then a junior faculty member in the Division of Rheumatology, Immunology and Allergy at Brigham and Women’s Hospital in Boston. As a research fellow and assistant professor at Harvard Medical School in the 1990s, he pioneered studies on the CD1 antigen presentation pathway and lipid antigen recognition by T cells. These studies led him into the area of tuberculosis research, with a major emphasis on antigen presentation and T cell responses in Mycobacterium tuberculosis infection. In 2000, Dr. Porcelli was recruited to Einstein to be the Irene Diamond Associate Professor in Immunology, and was subsequently appointed the Murray and Evelyne Weinstock Chair in Microbiology and Immunology. Beginning in 2015, he was appointed Chair of the Department of Microbiology and Immunology. His laboratory has focused for the past fifteen years on uncovering the immune evasion mechanisms of M. tuberculosis with the goal of rationally designing improved vaccines. He and colleagues at Einstein have identified genes of M. tuberculosis that contribute to evasion of cell-mediated immunity. Dr. Porcelli and his colleagues are using this information to create new attenuated strains of mycobacteria that will be assessed for their potential to more effectively induce protective immunity against tuberculosis than the existing Bacillus Calmette-Guérin vaccine. His lab is also pursuing research on the creation of improved adjuvants for a variety of types of vaccines, and novel methods for enhancing immune responses against cancers. Dr. Porcelli is a fellow of the American Society for Clinical Investigation, and is the scientific director of the Flow Cytometry Core Laboratories at Einstein.